SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-031744
Filing Date
2020-11-19
Accepted
2020-11-19 20:15:04
Documents
1
Period of Report
2020-11-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9093
  Complete submission text file 0000899243-20-031744.txt   10614
Mailing Address C/O NEW LEAF VENTURE PARTNERS TIMES SQ TOWER, 7 TIMES SQ, STE 3502 NEW YORK NY 10036
Business Address
Becker Daniel J. (Reporting) CIK: 0001752139 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39381 | Film No.: 201330220

Mailing Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472 617-393-5925
Pandion Therapeutics, Inc. (Issuer) CIK: 0001807901 (see all company filings)

IRS No.: 833015614 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences